 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE-- DNA--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it intends to offer and sell in an underwritten public offering up to 250 million of shares of its common stock and certain selling stockholders intend to offer 75,000 shares in the offering. In addition, Twist intends to grant the underwriters a 30-day option to pur 